Viewing StudyNCT00476853



Ignite Creation Date: 2024-05-05 @ 5:32 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00476853
Status: COMPLETED
Last Update Posted: 2020-07-17
First Post: 2007-05-20

Brief Title: Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy
Sponsor: The HIV Netherlands Australia Thailand Research Collaboration
Organization: The HIV Netherlands Australia Thailand Research Collaboration

Conditions & Keywords Data

Conditions:
Name
Tuberculosis
HIV Infections
Keywords:
Name View
Treatment Naive View
HIV-TB View
nevirapine based HAART with rifampin treated TB View
Compare PK profile efficacy safety and tolerability of HAART containing nevirapine 400mgday versus 600 mgday in HIVTB co-infected patients View